These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16565850)

  • 1. Familial occurrence of moyamoya disease: a clinical study.
    Seol HJ; Wang KC; Kim SK; Hwang YS; Kim KJ; Cho BK
    Childs Nerv Syst; 2006 Sep; 22(9):1143-8. PubMed ID: 16565850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment.
    Kim SK; Seol HJ; Cho BK; Hwang YS; Lee DS; Wang KC
    Neurosurgery; 2004 Apr; 54(4):840-4; discussion 844-6. PubMed ID: 15046649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of familial juvenile cases of moyamoya disease: analysis of patients treated in a single institute over a 28-year period.
    Mukawa M; Nariai T; Matsushima Y; Ohno K
    J Neurosurg Pediatr; 2013 Aug; 12(2):175-80. PubMed ID: 23725354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
    Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
    Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involuntary movement induced by cerebral ischemia: pathogenesis and surgical outcome.
    Im SH; Oh CW; Kwon OK; Cho BK; Chung YS; Han DH
    J Neurosurg; 2004 May; 100(5):877-82. PubMed ID: 15137607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease.
    Zhang Q; Wang R; Liu Y; Zhang Y; Wang S; Cao Y; Zhao Y; Liu X; Wang J; Deng X; Gao F; Yang Z; Zhao M; Ge P; Ma Y; Zhao J; Zhang D
    World Neurosurg; 2016 Dec; 96():474-482. PubMed ID: 27647029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cerebral hemodynamics with perfusion MRI in childhood moyamoya disease.
    Kim SK; Wang KC; Oh CW; Kim IO; Lee DS; Song IC; Cho BK
    Pediatr Neurosurg; 2003 Feb; 38(2):68-75. PubMed ID: 12566838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.
    Zhang Q; Zhang D; Wang R; Liu Y; Zhang Y; Wang S; Zhao J
    World Neurosurg; 2016 Jun; 90():530-538.e3. PubMed ID: 26806063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention.
    Lee JY; Phi JH; Wang KC; Cho BK; Shin MS; Kim SK
    Cerebrovasc Dis; 2011; 31(3):230-7. PubMed ID: 21178347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.
    Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang R; Zhang Y; Zhang D; Zhao J
    World Neurosurg; 2017 Apr; 100():459-466. PubMed ID: 28132922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar TIAs and corresponding alterations in regional cerebral perfusion in Caucasian monozygotic twins with moyamoya disease.
    Linfante I; Ciarmiello A; Fusco C; Ronga B; Andreone V
    Clin Imaging; 2002; 26(6):378-81. PubMed ID: 12427431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and radiographic features of moyamoya disease in patients with both cerebral ischaemia and haemorrhage.
    Hishikawa T; Tokunaga K; Sugiu K; Date I
    Br J Neurosurg; 2013 Apr; 27(2):198-201. PubMed ID: 22934580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.
    Han JH; Park YS; Lee WH; Koong SS; Min KS; Lee MS; Kim YG; Kim DH; Yi KS; Cha SH
    Childs Nerv Syst; 2016 Aug; 32(8):1471-7. PubMed ID: 26661381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease.
    Cho HJ; Jung YH; Kim YD; Nam HS; Kim DS; Heo JH
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):38-40. PubMed ID: 20587492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.